Skip to main content

Table 4 CD40+ MC is a novel and stronger pro-inflammatory MC subset compared with intermediated MC

From: Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation

Inflammatory surface maker

Pro-inflammatory MC

Anti-inflammatory MC

CD40+ MC (CD40+CD14+)

Intermediate MC (CD14++CD16+)

CD40− MC (CD40−CD14+)

Non-classical MC (CD14+CD16++)

TC activation receptor

 CD86

+++

++

+

+

 CD80

+

+

+

+

 LA-DR

++

++

+

+++

Adhesion receptor

 CD62L

++

++

++

+

 CD11b

+++

+++

+

+

 CD49d

+++

+++

+

+++

Chemokine receptor

 CCR2

+++

+

++

+

 CCR5

+++

+++

+

+

 CX3CR1

+++

+++

++

+++

  1. Inflammatory features of human CD40+ MC were characterized using nine inflammatory surface makers by flow cytometry analysis (experimental details in Yang et al. [15]). WBC from healthy subjects were isolated and stained with anti-CD14, anti-CD16, and anti-CD40 antibodies and co-stained with surface markers for TC activation (CD86, CD80, and HLA-DR), adhesion receptors (CD62L, CD11b, and CD49d), and chemokine receptors (CCR2, CCR5, and CX3CR1). Compared with the previously established inflammatory intermediate MC subset, CD40+ MC expressed higher levels of CD86 and CCR2 and similar levels of other inflammatory markers. CD40− MC expressed much lower levels of HLA-DR, CD49d, and CX3CR1 and similar levels of other inflammatory markers compared with non-classic MC
  2. Abbreviations: MC monocyte, TC T cell, WBC white blood cells